Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

  • Quoted phrase not found.
1.

Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1.

Li S, Liu F, Pei Y, Wang W, Zheng K, Zhang X.

Aging (Albany NY). 2019 Sep 16;11(18):7678-7693. doi: 10.18632/aging.102280. Epub 2019 Sep 16.

2.

Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer.

Gao Y, Li X, Zhi H, Zhang Y, Wang P, Wang Y, Shang S, Fang Y, Shen W, Ning S, Chen SX, Li X.

Mol Ther Nucleic Acids. 2019 Aug 14;18:66-79. doi: 10.1016/j.omtn.2019.08.004. [Epub ahead of print]

3.

LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.

Duan H, Li X, Chen Y, Wang Y, Li Z.

Life Sci. 2019 Sep 13:116856. doi: 10.1016/j.lfs.2019.116856. [Epub ahead of print]

PMID:
31525429
4.

Community Curation and Expert Curation of Human Long Noncoding RNAs with LncRNAWiki and LncBook.

Ma L, Cao J, Liu L, Li Z, Shireen H, Pervaiz N, Batool F, Raza RZ, Zou D, Bao Y, Abbasi AA, Zhang Z.

Curr Protoc Bioinformatics. 2019 Sep;67(1):e82. doi: 10.1002/cpbi.82.

PMID:
31524988
5.

Linc01105 acts as an oncogene in the development of neuroblastoma.

Ye M, Ma J, Liu B, Liu X, Ma D, Dong K.

Oncol Rep. 2019 Aug 2. doi: 10.3892/or.2019.7257. [Epub ahead of print]

PMID:
31524279
6.

Casiopeina II‑gly acts on lncRNA MALAT1 by miR‑17‑5p to inhibit FZD2 expression via the Wnt signaling pathway during the treatment of cervical carcinoma.

Xu Y, Zhang Q, Lin F, Zhu L, Huang F, Zhao L, Ou R.

Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7268. [Epub ahead of print]

7.

Long non‑coding RNA SLNCR1 regulates non‑small cell lung cancer migration, invasion and stemness through interactions with secretory phospholipase A2.

Xu W, Xu Q, Kuang D, Wang Z, Lu Q, Lin Q, Wu H, Chen L.

Mol Med Rep. 2019 Sep;20(3):2591-2596. doi: 10.3892/mmr.2019.10518. Epub 2019 Jul 23.

8.

Long non‑coding RNA MEG‑3 suppresses gastric carcinoma cell growth, invasion and migration via EMT regulation.

Jiao J, Zhang S.

Mol Med Rep. 2019 Sep;20(3):2685-2693. doi: 10.3892/mmr.2019.10515. Epub 2019 Jul 23.

9.

MicroRNA-592 suppresses the malignant phenotypes of thyroid cancer by regulating lncRNA NEAT1 and downregulating NOVA1.

Luo Y, Hao T, Zhang J, Zhang M, Sun P, Wu L.

Int J Mol Med. 2019 Sep;44(3):1172-1182. doi: 10.3892/ijmm.2019.4278. Epub 2019 Jul 16.

PMID:
31524231
10.

A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma.

Huang G, Huang Q, Xie Z, Zhou H, Cao J, Shi L, Yang M.

Cancer Biomark. 2019 Sep 6. doi: 10.3233/CBM-182275. [Epub ahead of print]

PMID:
31524143
11.

Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.

Shang W, Adzika GK, Li Y, Huang Q, Ding N, Chinembiri B, Rashid MS, Machuki JO.

Cancer Med. 2019 Sep 15. doi: 10.1002/cam4.2553. [Epub ahead of print] Review.

12.

Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer.

Sun F, Liang W, Tang K, Hong M, Qian J.

PeerJ. 2019 Aug 26;7:e7451. doi: 10.7717/peerj.7451. eCollection 2019.

13.

Corrigendum: Long Non-coding RNA Structure and Function: Is There a Link?

Zampetaki A, Albrecht A, Steinhofel K.

Front Physiol. 2019 Sep 3;10:1127. doi: 10.3389/fphys.2019.01127. eCollection 2019.

14.

The Association between lncRNA LINC01296 and the Clinical Characteristics in Neuroblastoma.

Wang J, Wang Z, Yao W, Dong K, Zheng S, Li K.

J Pediatr Surg. 2019 Aug 29. pii: S0022-3468(19)30572-X. doi: 10.1016/j.jpedsurg.2019.08.032. [Epub ahead of print]

PMID:
31522796
15.

Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.

Buishand FO, Liu-Chittenden Y, Fan Y, Tirosh A, Gara SK, Patel D, Meerzaman D, Kebebew E.

Surgery. 2019 Sep 12. pii: S0039-6060(19)30548-3. doi: 10.1016/j.surg.2019.04.067. [Epub ahead of print]

PMID:
31522749
16.

FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.

Xiao G, Wang P, Zheng X, Liu D, Sun X.

Cell Cycle. 2019 Nov;18(21):2972-2985. doi: 10.1080/15384101.2019.1664225. Epub 2019 Sep 16.

PMID:
31522616
17.

Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers.

Farhan M, Aatif M, Dandawate P, Ahmad A.

Adv Exp Med Biol. 2019;1152:229-241. doi: 10.1007/978-3-030-20301-6_11. Review.

PMID:
31456186

Supplemental Content

Loading ...
Support Center